In addition, we performed double-labeling immunofluorescence stainings for SPARC and p53 or SPARC and EGFRvIII on selected tumors which also revealed SPARC expression by glioblastoma cells being positive for either of these tumor cell-specific markers [Suppl. The gene discussed is TP53; the disease is glioblastoma.